Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor
Tiffany Chang(Tulane University), Bridgette M. Collins‐Burow(Tulane University)
Cited by 18
Related Papers
Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
|Breast Cancer Research|2012|263